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 Supplementary Table S1. Yeast strains used in this study. 
Strains Genotypes Sources 
TB50α MATα trp1 his3 ura3 leu2 rme1 [ρ+] Lab. stock 
RL170-2b TB50α TCO89-TAP[KlTrp1] [ρ+] Lab. stock 
YGSK226 TB50α TCO89-TAP[KlTrp1] pJU676 pJU450 [ρ+] This study 
YGSK232 TB50α TCO89-TAP[KlTrp1] [ρ0] This study 
YGSK242 TB50α TCO89-TAP[KlTrp1] pJU676 pJU450 [ρ0] This study 
YGSK269 TB50α TCO89-TAP[KlTrp1] pJU675 pJU450 [ρ+] This study 
YGSK270 TB50α TCO89-TAP[KlTrp1] pJU841 pJU450 [ρ+] This study 
YGSK271 TB50α TCO89-TAP[KlTrp1] pJU675 pJU450 [ρ0] This study 
YGSK272 TB50α TCO89-TAP[KlTrp1] pJU841 pJU450 [ρ0] This study 
TB50a MATa trp1 his3 ura3 leu2 rme1 [ρ+] Lab. stock 
RL276-5D TB50a  HIS3 LEU2 [ρ+] Lab. stock 
YGSK239 a TB50a  HIS3 LEU2 [ρ0] This study 
YGSK197 a TB50a TCO89-TAP[KlTrp1] kog1Δ::kanMX6 snf1Δ::hph 
YCplac111::KOG1 [ρ+] This study 
BY4742 MATα leu2Δ0 lys2Δ0 ura3Δ0 his3Δ1 [ρ+] Euroscarf 
YGSK229 BY4742 pJU676 pJU450 [ρ+] This study 
YGSK233 a BY4742 [ρ0] This study 
YGSK243 BY4742 pJU676 pJU450 [ρ0] This study 
BY4741 MATa leu2Δ0 met15Δ0 ura3Δ0 his3Δ1 [ρ+] Euroscarf 
YGSK238 a BY4741 [ρ0] This study 
YGSK221 BY4741 atp2Δ::kanMX4 [ρ+] Euroscarf 
YGSK247 BY4741 atp2Δ::kanMX4 pJU676 pJU450 [ρ+] This study 
YGSK219 BY4741 cox6Δ::kanMX4 [ρ+] Euroscarf 
YGSK248 a BY4741 cox6Δ::kanMX4 pJU676 pJU450 [ρ+] This study 
YGSK222 BY4741 mrpl16Δ::kanMX4 [ρ+] Euroscarf 
YGSK249 BY4741 mrpl16Δ::kanMX4 pJU676 pJU450 [ρ+] This study 
MK3306 BY4742 pRS315 pJU676 pRS413 [ρ+] This study 
MK3307 BY4742 pRS315 pJU676 pRS413 [ρ0] This study 
MK3309 b BY4742 pPL132 (pRS315::TOR1) pRS413 pJU450 [ρ0] This study 
MK3311 b BY4742 pPL156 (pRS315::TOR1 I1954V) pRS413 pJU450 
[ρ0] 
This study 
MK3313 b BY4742 pPL158 (pRS315::TOR1 I1954V W2176R) pRS413 
pJU450 [ρ0] 
This study 
MK3354 c BY4742 gtr1Δ::kanMX4 YCplac33::pTetON-GTR1-Q65L 
pJU679 pRS413 [ρ+] 
This study 
MK3355 BY4742 gtr1Δ::kanMX4 YCplac33 pJU679 pRS413 [ρ+] This study 
MK3356 c BY4742 gtr1Δ::kanMX4 YCplac33::pTetON-GTR1-Q65L 
pJU679 pRS413 [ρ0] 
This study 
MK3357 BY4742 gtr1Δ::kanMX4 YCplac33 pJU679 pRS413 [ρ0] This study 
a These strains were used for checking ρ+ or ρ0 phenotype. 
b Plasmids (pPL132, 156, and 158) were kindly gifted from Dr. Ted Powers (3). 
c Plasmid (YCplac33::pTetON-GTR1-Q65L) is described in ref (2).
 
  
 
 
 
Fig. S1 
 
Figure legend of Supplementary Fig. S1 
 
FIG. S1 (A) Accumulation of glycogen. YGSK229 (WT ρ+), YGSK243 (WT ρ0), and 
YGSK248 (cox6 ρ+) (cox6 ρ+) cells were diluted to an A600 of 0.4 in fresh SD+Asn 
medium (containing: 2 % glucose, 10 mM Asn, 0.17 % yeast nitrogen base without 
ammonium sulfate [pH 5.6] plus 50 μg/ml Lys for YGSK229 and YGSK243, 20 µg/ml 
Met for YGSK248) and cultivated for approximately 4.5 h. YGSK229 cells were also 
cultivated in another flask as above for 3 h, and further cultivated for 1.5 h in the 
presence of 200 ng/ml rapamycin. 7.5 A600 equivalents of cells were filtered and treated 
with iodine vapour to stain glycogen as described (1). Dark staining indicates that 
glycogen was accumulated in; YGSK243 (WT ρ0) and rapamycin-treated YGSK229 
(Rap+ WT ρ+) cells, but not in YGSK229 (WT ρ+) and YGSK248 (cox6 ρ+) cells. (B) 
Sch9 is dephosphorylated independently of GTR1 in ρ0 cells. MK3354 (gtr1 
YCplac33::pTetON-GTR1-Q65L ρ+), MK3355 (gtr1 YCplac33 ρ+), MK3356 (gtr1 
YCplac33::pTetON-GTR1-Q65L ρ0), and MK3357 (gtr1 YCplac33 ρ0) cells were 
cultured in SD+Asn medium containing 50 μg/ml Lys and 5 μg/ml doxycycline, diluted 
to an OD600 of 0.4 in the same medium, and further cultivated for 5.5 h. 
Sch9-phopshorylations were monitored as described in the text. Prior to SDS-PAGE / 
anti-HA blot, protein extracts were treated with NTCB to cleave proteins.  
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